Lead sponsor
High Point Pharmaceuticals, LLC.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
7
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's DiseaseAlzheimer's diseasePh 1Terminated7